Advanced Flower Capital (AFCG) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
24 Apr, 2026Company overview
First NASDAQ-listed commercial mortgage REIT focused on lending to state-compliant cannabis operators in the U.S., with $779M total capital committed since inception and $436M in current commitments as of May 2024.
Targets attractive risk-adjusted returns with estimated loan yields of 12–20%+ and maintains a robust investment review process.
Management team has structured over $15B in loans and taken four companies public; holds a BBB+ investment grade rating.
Investment highlights
Cycle-tested leadership with deep lending and investment management experience.
Strong risk-adjusted returns due to constrained capital in the cannabis sector, targeting IRRs of 12–20%.
Early mover in a growing, high-barrier market with disciplined investment processes and active portfolio management.
Strategic goals and portfolio management
2024 goals include optimizing the portfolio, advancing underwriting, and sourcing over $100M in new investments.
Recent successful loan exits and portfolio expansion, with top three loans now representing a reduced share of assets, indicating diversification.
Latest events from Advanced Flower Capital
- Q1 2026 net investment income was $4.8M, NAV per share rose to $7.90, and a $5M buyback was authorized.AFCG
Q1 20267 May 2026 - BDC conversion expanded investment scope; $1.4B pipeline, $366M principal outstanding in 2025.AFCG
Q4 202527 Apr 2026 - Board recommends director elections and auditor ratification, with strong governance and oversight.AFCG
Proxy filing17 Apr 2026 - Vote on director elections and auditor ratification at the May 2026 annual meeting.AFCG
Proxy filing17 Apr 2026 - Q2 2025 net loss of $13.2M, $3.4M distributable earnings, and BDC conversion planned.AFCG
Q2 202510 Mar 2026 - Q2 net income reached $16.4M as the company became a pure-play cannabis lender.AFCG
Q2 20242 Feb 2026 - Q3 2024 earnings met targets, with strong originations and higher risk post-CRE spin-off.AFCG
Q3 202414 Jan 2026 - Exceeded origination targets, delivered strong yields, and maintained a robust pipeline.AFCG
Q4 202424 Dec 2025 - REIT lender to cannabis sector files $1B shelf registration for flexible equity and debt offerings.AFCG
Registration Filing16 Dec 2025